Document is current
Any future updates will be listed below
-
Authors
Wijngaarden, Jessica E. https://orcid.org/0000-0003-1486-6246
Slebe, Maarten https://orcid.org/0000-0001-8056-1235
Pouw, Johanna E. E.
Oprea-Lager, Daniela E.
Schuit, Robert C.
Dickhoff, Chris
Levi, Jelena
Windhorst, Albert D.
Oordt, C. Willemien Menke-van der Houven v
Thiele, Andrea
Bahce, Idris
Boellaard, Ronald
Yaqub, Maqsood
-
Funding
Funding for this research was provided by:
Boehringer Ingelheim (Boehringer Ingelheim)
- License Information
-
More Information
Article History
Received: 28 March 2024
Accepted: 26 September 2024
First Online: 8 October 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Amsterdam University Medical Center.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Andrea Thiele is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. CellSight Technologies (CST) is commercializing [18F]F-AraG. Jelena Levi holds an equity interest in CST and patents related to [18F]F-AraG.
